| 产品描述: | AST5902 trimesylate is the principal metabolite of Alflutinib (AST2818) both in vitro and in vivo. AST5902 trimesylate exerts antineoplastic activity. Alflutinib is an EGFR inhibitor. |
| 靶点: |
EGFR |
| 参考文献: |
1. Xiao-yun Liu, et al. Alflutinib (AST2818), primarily metabolized by CYP3A4, is a potent CYP3A4 inducer. Acta Pharmacol Sin. 2020 Oct; 41(10): 1366-1376. |
| 保存条件: |
-20°C,干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.186 ml |
5.932 ml |
11.864 ml |
| 5 mM |
0.237 ml |
1.186 ml |
2.373 ml |
| 10 mM |
0.119 ml |
0.593 ml |
1.186 ml |
| 50 mM |
0.024 ml |
0.119 ml |
0.237 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |